Gene by Gene Forensic Genomics Firm Othram Raises $4M The company also said it has been awarded a research sequencing grant from Illumina Accelerator. Family Tree DNA Challenges Alaska Genetic Privacy Law in Wake of Lawsuit Premium Parent firm Gene by Gene calls the law "brief and vague" and is pushing for ancestry testing to be exempt from the provision of the genetic privacy statute. Consumer Genomics Market Should Pass 'Tipping Point' of 3 Million Samples Tested in 2015 Premium The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents. For Consumer Genomics Market, 2014 was a Year of New Features, New Players, and 'Unmatched' Sales Premium Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors. 23andMe Scientists Offer Closer Look at Ancestry Composition Analysis Tool in New Paper Premium NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper. Apr 1, 2014 Gene by Gene Plans US Launch for Clinical Carrier Screening Array Focused on Jewish Populations Premium Mar 18, 2014 Family Tree DNA's NGS-Based 'BigY' Service to Inform Future Generations of Ancestry Testing Chips Premium Feb 25, 2014 Questions Abound about 23andMe's Ancestry Testing Business at RootsTech Conference Premium Feb 18, 2014 At RootsTech, Consumer Genomics Players, Observers Discuss New Trends, Tools, and Chips Premium Feb 18, 2014 Gene by Gene's Clinical, Research Arrays Exempt from New Myriad BRCA Testing Agreement Premium Feb 7, 2014 Gene by Gene Settles BRCA Patent Infringement Suit with Myriad Genetics, Other IP Owners Dec 17, 2013 Citing Throughput Advantages, FTDNA Joins 23andMe in Moving to New 24-Sample Illumina Chip Format Premium Nov 12, 2013 Family Tree DNA Expands beyond Array-based Offerings with New Y Chromosome Sequencing Service Premium Oct 22, 2013 Myriad Sues Third Firm, BioReference's GeneDx, Alleging BRCA1/2 Patent Infringement Oct 1, 2013 With Sequencing Ancestry Test Launch, Startup Full Genomes Enters Array-Dominated Market Premium Aug 28, 2013 GeneDx Launches Suite of Inherited Cancer Panels, Including BRCA1 and BRCA2 Genes Premium Aug 15, 2013 Gene by Gene Joins Ambry in Countersuit against Myriad Alleging Antitrust Violations Aug 9, 2013 Gene by Gene Acquires Arpeggi to Extend Genetic Testing and Diagnostic Offerings Premium Aug 7, 2013 Not Backing Down in BRCA Test Infringement Case, Ambry Slaps Myriad with Antitrust Countersuit Premium Aug 7, 2013 Gene by Gene Buys Arpeggi in a Deal to Accelerate Genetic Testing, Dx Services Jul 10, 2013 Myriad, Others Sue Gene by Gene Alleging Infringement of BRCA 1/2 Patents Jul 10, 2013 In Warning to Would-be Competitors, Myriad and BRCA Test Patent Holders Sue Ambry, Gene by Gene Premium Jun 19, 2013 With New BRCA Testing Options, Patient Groups Advise Women to Speak to Genetics Expert, Share Reports Premium Apr 24, 2013 Gene by Gene, MD Anderson to Boost Aspiring Molecular Genetic Technologists' NGS Skills Premium Apr 23, 2013 Gene By Gene to Support MD Anderson Genomics Education Program Load More Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.